GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Goodrx Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.071 -- 00:00:04.993 Ladies and gentlemen, thank you for standing by and welcome to the GoodRx second quarter 00:00:04.993 -- 00:00:06.474 2026 00:00:06.474 -- 00:00:11.397 earnings call. As a reminder, today's conference call is being recorded. 00:00:11.397 -- 00:00:15.739 I would now like to introduce your host for today's call, Aubrey Reynolds, Director of 00:00:15.739 -- 00:00:20.020 Investor Relations. Ms. Reynolds, you may begin. 00:00:20.061 -- 00:00:24.063 Thank you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference 00:00:24.063 -- 00:00:27.209 call for the second quarter 2026. 00:00:27.209 -- 00:00:31.912 Joining me today are Wendy Barnes, our Chief Executive Officer, and Justin Fengler, our 00:00:31.912 -- 00:00:34.694 newly appointed Chief Financial Officer. 00:00:34.694 -- 00:00:38.757 Before we begin, I'd like to remind everyone that this call will contain forward-looking 00:00:38.757 -- 00:00:40.318 statements. 00:00:40.318 -- 00:00:44.500 All statements made on this call that do not relate to matters of historical fact should 00:00:44.500 -- 00:00:49.463 be considered forward-looking statements, including, without limitation, statements regarding 00:00:49.463 -- 00:00:54.787 management's plans, strategies, goals and objectives, our market opportunity, 00:00:54.787 -- 00:00:59.538 our anticipated financial performance, underlying trends in our business and industry, 00:00:59.538 -- 00:01:04.860 including ongoing changes in the pharmacy ecosystem, our value proposition, our long-term 00:01:04.860 -- 00:01:10.263 growth prospects, our direct and hybrid contracting approach, collaborations and partnerships 00:01:10.263 -- 00:01:14.265 with third parties, including our point of sale cash programs and our integrated...